Business of Bioanalysis: Evolving the Use of Bioanalytical Platforms

Watch Dr. Afshin Safavi, BioAgilytix Global CSO discuss how platforms are being adapted for use in later stages of drug development as part of the “Business of Bioanalysis” panel hosted by Bioanalysis Zone.

*Video Produced by Bioanalysis Zone

Share This